PL2925293T3 - Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania - Google Patents
Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowaniaInfo
- Publication number
- PL2925293T3 PL2925293T3 PL13792728T PL13792728T PL2925293T3 PL 2925293 T3 PL2925293 T3 PL 2925293T3 PL 13792728 T PL13792728 T PL 13792728T PL 13792728 T PL13792728 T PL 13792728T PL 2925293 T3 PL2925293 T3 PL 2925293T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- application
- local use
- tetracycline formulations
- tetracycline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106679A PT106679B (pt) | 2012-11-27 | 2012-11-27 | Formulações tópicas de tetraciclinas, sua preparação e usos |
| PCT/GB2013/052939 WO2014083311A1 (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
| EP13792728.1A EP2925293B1 (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2925293T3 true PL2925293T3 (pl) | 2017-12-29 |
Family
ID=49620233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13792728T PL2925293T3 (pl) | 2012-11-27 | 2013-11-08 | Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9592246B2 (pl) |
| EP (1) | EP2925293B1 (pl) |
| JP (1) | JP6444308B2 (pl) |
| KR (1) | KR102235922B1 (pl) |
| CN (1) | CN104902875B (pl) |
| AU (1) | AU2013350941B2 (pl) |
| BR (1) | BR112015012162B1 (pl) |
| CA (1) | CA2895395C (pl) |
| DK (1) | DK2925293T3 (pl) |
| ES (1) | ES2645449T3 (pl) |
| HU (1) | HUE034932T2 (pl) |
| IL (1) | IL239022B (pl) |
| MX (1) | MX355174B (pl) |
| NO (1) | NO2925293T3 (pl) |
| NZ (1) | NZ708824A (pl) |
| PL (1) | PL2925293T3 (pl) |
| PT (1) | PT106679B (pl) |
| RU (1) | RU2639591C2 (pl) |
| SG (1) | SG11201504145PA (pl) |
| WO (1) | WO2014083311A1 (pl) |
| ZA (1) | ZA201504369B (pl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| JP2006505583A (ja) | 2002-10-25 | 2006-02-16 | フォーミックス エルティーディー． | 化粧剤および医薬用フォーム |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US20180228811A1 (en) * | 2014-12-12 | 2018-08-16 | The Schepens Eye Research Institute, Inc. | Gdnf induction for the treatment of retinal disorders |
| EP3261619A4 (en) * | 2015-02-25 | 2018-10-24 | Sun Pharma Advanced Research Company Ltd | Nanoparticulate composition |
| CA2980527A1 (en) | 2015-03-23 | 2016-09-29 | BioPharmX, Inc. | Pharmaceutical tetracycline composition for dermatological use |
| CN105380900B (zh) * | 2015-11-25 | 2018-05-29 | 徐州医学院 | 一种治疗痤疮的纳米磁疗外用凝胶及其制备方法和应用 |
| MX377365B (es) | 2016-09-08 | 2025-03-10 | Journey Medical Corp | Composiciones y métodos para tratar rosácea y acné. |
| FR3064482B1 (fr) * | 2017-04-03 | 2020-11-13 | Horus Pharma | Composition topique de doxycycline |
| WO2019082090A1 (en) * | 2017-10-24 | 2019-05-02 | Glenmark Pharmaceuticals Limited | TOPICAL PHARMACEUTICAL COMPOSITION OF ADAPALENE AND MINOCYCLIN |
| JP7386170B2 (ja) | 2017-11-28 | 2023-11-24 | シーレクター ゲーエムベーハー | トレハロースホスホリラーゼバリアントを使用するトレハロースの生産方法 |
| US11191740B2 (en) | 2018-01-07 | 2021-12-07 | Dr. Reddy's Laboratories Ltd. | Methods for treating inflammatory skin conditions |
| US11202788B2 (en) | 2019-08-22 | 2021-12-21 | Nanopharmaceutics, Inc. | Topical doxycycline hydrogel with improved long-term stability |
| WO2021191273A1 (en) | 2020-03-24 | 2021-09-30 | Hovione Scientia Limited | Compositions for use in treating meibomian gland dysfunction |
| WO2022043457A1 (en) | 2020-08-27 | 2022-03-03 | Hovione Scientia Limited | Methods and compositions for treating rosacea |
| WO2022090302A1 (en) * | 2020-10-28 | 2022-05-05 | Hovione Scientia Limited | Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders |
| CN115463091B (zh) * | 2022-10-27 | 2023-04-07 | 新基元(北京)医药科技有限公司 | 一种改善稳定性的米诺环素泡沫剂 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB769274A (en) * | 1954-04-22 | 1957-03-06 | Pfizer | Therapeutic preparations of tetracycline antibiotics in oil |
| GB1581335A (en) | 1976-07-05 | 1980-12-10 | Leo Pharm Prod Ltd | 16-s-acyl derivatives of fusidic acid |
| US4505896A (en) | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| JPS5788115A (en) * | 1980-10-06 | 1982-06-01 | Miles Lab | Stable non-aqueous solution of tetracycline antibiotic salt |
| US5122519A (en) * | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| US5874479A (en) | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US6113921A (en) | 1993-03-23 | 2000-09-05 | Pharmos Corp. | Topical and transdermal delivery system utilizing submicron oil spheres |
| US5905092A (en) | 1994-09-27 | 1999-05-18 | Virotex Corporation Reel/Frame | Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction |
| US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
| JP2000504706A (ja) * | 1996-02-16 | 2000-04-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗真菌薬及び硫黄化合物を含有する組成物 |
| JPH09255578A (ja) * | 1996-03-22 | 1997-09-30 | Sekisui Chem Co Ltd | 感染性皮膚疾患治療用外用剤 |
| US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| US6433068B1 (en) * | 1997-03-07 | 2002-08-13 | David S. Morrison | Hydrocarbon gels as suspending and dispersing agents and products |
| DE69940227D1 (de) * | 1998-05-08 | 2009-02-12 | Univ Miami | Verwendung von sub-antimikrobiellen tetracyclinen zur Behandlung von okularer Rosacea |
| US20030007939A1 (en) | 1998-07-31 | 2003-01-09 | Howard Murad | Pharmaceutical compositions and methods for managing dermatological conditions |
| US6432934B1 (en) * | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| KR20010075053A (ko) * | 1999-07-12 | 2001-08-09 | 도리이 신이찌로 | 국소 투여용 의약 조성물 |
| US6946118B1 (en) | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6667045B2 (en) | 1999-10-01 | 2003-12-23 | Joseph Scott Dahle | Topical applications for skin treatment |
| US20030077301A1 (en) | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| US20020010162A1 (en) | 2000-03-02 | 2002-01-24 | Raul Fleischmajer | Treatment of psoriasis with matrix metalloproteinase inhibitors |
| US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| JP4653282B2 (ja) * | 2000-05-23 | 2011-03-16 | 昭和薬品化工株式会社 | ミノサイクリン含有組成物 |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| JP2004525955A (ja) * | 2001-04-05 | 2004-08-26 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | テトラサイクリン化合物およびテトラサイクリン誘導体の制御された伝達 |
| JP4745608B2 (ja) | 2001-07-27 | 2011-08-10 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 電子伝達剤のリン酸誘導体を用いた皮膚治療 |
| SI1553967T1 (sl) | 2002-06-17 | 2011-07-29 | Naicons S C A R L | Uporaba amid derivata GE 2270 faktorja A3 za zdravljenje aken |
| US20040076699A1 (en) * | 2002-07-15 | 2004-04-22 | Chaudhuri Ratan K. | Topical anhydrous delivery system |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| CA2525786A1 (en) | 2003-06-11 | 2004-12-23 | The Procter & Gamble Company | Preparation-at-use device comprising pre-formed hydrogel product |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US7241746B2 (en) | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
| US8916050B2 (en) | 2004-09-27 | 2014-12-23 | Special Water Patents B.V. | Methods and compositions for treatment of water |
| US7531164B2 (en) | 2005-10-21 | 2009-05-12 | Duke University | Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| GB2432529B (en) | 2005-11-25 | 2008-04-23 | Univ Feng Chia | Antimicrobial compositions and wound dressings |
| JP4959991B2 (ja) * | 2006-03-03 | 2012-06-27 | 株式会社日本点眼薬研究所 | トラニラストまたはその薬理学的に許容される塩を含有する懸濁性医薬組成物 |
| WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| US20080188446A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
| CA2679448A1 (en) | 2007-02-28 | 2008-09-04 | Aciex, Inc. | Methods and compositions for normalizing meibomian gland secretions |
| AU2008231033B2 (en) * | 2007-03-23 | 2012-08-30 | Molecular Research Center, Inc. | Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy |
| ES2349906T3 (es) | 2007-07-25 | 2011-01-12 | Ixodes Gmbh | Composición antibiótica tópica para prevenir la enfermedad de lyme. |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| GB0800145D0 (en) * | 2008-01-04 | 2008-02-13 | Reckitt Benckiser Uk Ltd | Skincare treatment |
| JP5674020B2 (ja) * | 2008-03-28 | 2015-02-18 | アンジェスＭｇ株式会社 | 転写因子デコイを有効成分とする外用剤組成物 |
| EP2282714B1 (en) * | 2008-04-29 | 2017-12-13 | Hair Systems, Inc. | Composition and method for cream bleach product |
| US20100029765A1 (en) | 2008-07-30 | 2010-02-04 | Ranbaxy Labortories Limited | Topical aqueous composition comprising tretinoin |
| CA2734687A1 (en) * | 2008-08-18 | 2010-02-25 | Nanotherapeutics, Inc. | Topical hydrogel composition |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| PT104644B (pt) | 2009-06-26 | 2012-11-06 | Hovione Farmaciencia S A | Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma |
| US9155915B2 (en) | 2009-07-27 | 2015-10-13 | Dermadoctor, Inc. | Moisturizing retinol composition |
| GB2474930B (en) * | 2009-10-02 | 2012-07-04 | Foamix Ltd | Topical tetracycline compositions |
| US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US9011861B2 (en) | 2010-02-25 | 2015-04-21 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
| US20120082632A1 (en) | 2010-04-21 | 2012-04-05 | Phillips D Howard | Topical drug delivery system with dual carriers |
| CA2776482C (en) * | 2010-05-04 | 2022-06-07 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| PT105116B (pt) | 2010-05-14 | 2012-10-16 | Hovione Farmaciencia S A | Novas partículas de tetraciclina e agente protector. |
| BRPI1002601E2 (pt) | 2010-06-01 | 2020-06-30 | Embrapa Pesquisa Agropecuaria | composição nanoestruturada de uso veterinário para administração de fármacos |
| US20120093876A1 (en) * | 2010-10-13 | 2012-04-19 | Aciex, Inc. | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions |
| US8481591B2 (en) | 2010-11-01 | 2013-07-09 | Stiefel Research Australia Pty. Ltd. | Polymeric topical compositions |
| KR20140003573A (ko) | 2011-01-24 | 2014-01-09 | 안테리오스, 인코퍼레이티드 | 오일 조성물 |
-
2012
- 2012-11-27 PT PT106679A patent/PT106679B/pt active IP Right Grant
-
2013
- 2013-11-08 MX MX2015006632A patent/MX355174B/es active IP Right Grant
- 2013-11-08 DK DK13792728.1T patent/DK2925293T3/da active
- 2013-11-08 RU RU2015122786A patent/RU2639591C2/ru active
- 2013-11-08 SG SG11201504145PA patent/SG11201504145PA/en unknown
- 2013-11-08 HU HUE13792728A patent/HUE034932T2/en unknown
- 2013-11-08 CN CN201380068453.1A patent/CN104902875B/zh active Active
- 2013-11-08 AU AU2013350941A patent/AU2013350941B2/en not_active Ceased
- 2013-11-08 NZ NZ708824A patent/NZ708824A/en not_active IP Right Cessation
- 2013-11-08 EP EP13792728.1A patent/EP2925293B1/en active Active
- 2013-11-08 JP JP2015543515A patent/JP6444308B2/ja active Active
- 2013-11-08 US US14/074,868 patent/US9592246B2/en active Active - Reinstated
- 2013-11-08 NO NO13792728A patent/NO2925293T3/no unknown
- 2013-11-08 ES ES13792728.1T patent/ES2645449T3/es active Active
- 2013-11-08 KR KR1020157017068A patent/KR102235922B1/ko active Active
- 2013-11-08 BR BR112015012162-4A patent/BR112015012162B1/pt active IP Right Grant
- 2013-11-08 WO PCT/GB2013/052939 patent/WO2014083311A1/en not_active Ceased
- 2013-11-08 CA CA2895395A patent/CA2895395C/en active Active
- 2013-11-08 PL PL13792728T patent/PL2925293T3/pl unknown
-
2015
- 2015-05-26 IL IL239022A patent/IL239022B/en active IP Right Grant
- 2015-06-17 ZA ZA2015/04369A patent/ZA201504369B/en unknown
-
2017
- 2017-03-13 US US15/457,809 patent/US10213443B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6444308B2 (ja) | 2018-12-26 |
| US20170182071A1 (en) | 2017-06-29 |
| CN104902875A (zh) | 2015-09-09 |
| CN104902875B (zh) | 2018-04-03 |
| US9592246B2 (en) | 2017-03-14 |
| PT106679B (pt) | 2015-03-25 |
| AU2013350941A1 (en) | 2015-07-16 |
| WO2014083311A1 (en) | 2014-06-05 |
| ES2645449T3 (es) | 2017-12-05 |
| RU2015122786A (ru) | 2017-01-10 |
| US10213443B2 (en) | 2019-02-26 |
| MX355174B (es) | 2018-04-09 |
| IL239022B (en) | 2020-11-30 |
| EP2925293A1 (en) | 2015-10-07 |
| DK2925293T3 (da) | 2017-11-06 |
| IL239022A0 (en) | 2015-07-30 |
| NO2925293T3 (pl) | 2017-12-30 |
| HUE034932T2 (en) | 2018-03-28 |
| ZA201504369B (en) | 2017-01-25 |
| NZ708824A (en) | 2019-01-25 |
| MX2015006632A (es) | 2016-02-17 |
| KR102235922B1 (ko) | 2021-04-05 |
| PT106679A (pt) | 2014-05-27 |
| RU2639591C2 (ru) | 2017-12-21 |
| KR20150104102A (ko) | 2015-09-14 |
| EP2925293B1 (en) | 2017-08-02 |
| US20140147504A1 (en) | 2014-05-29 |
| SG11201504145PA (en) | 2015-07-30 |
| CA2895395A1 (en) | 2014-06-05 |
| BR112015012162B1 (pt) | 2021-02-23 |
| AU2013350941B2 (en) | 2018-04-26 |
| CA2895395C (en) | 2021-04-06 |
| JP2016500095A (ja) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2925293T3 (pl) | Formulacje tetracykliny do stosowania miejscowego, ich przygotowanie i zastosowania | |
| IL289759A (en) | Formulations for local disinfection and their uses | |
| CO6831975A2 (es) | Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso | |
| SI3725778T1 (sl) | Formulacije enzalutamida | |
| DK3216448T3 (da) | Paraciticide orale veterinære sammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| HUE036755T2 (hu) | Antimikrobiális vegyületek, valamint ezek elõállítása és alkalmazása | |
| BR112014012005A2 (pt) | composições, métodos, formulação farmacêutica e artigo | |
| IL237287A0 (en) | Antibody compositions and their uses | |
| EP2893918A4 (en) | ORAL COMPOSITION | |
| EP2846781A4 (en) | PROLIPOSOMAL TESTOSTERONE FORMULATIONS | |
| DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
| IL231444A0 (en) | Aniline derivativs, their preparation and their therapeutic application | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| IL233602A0 (en) | History of benzamide, their preparation and pharmaceutical preparations containing them | |
| DK2888100T3 (da) | Fremstillingsfremgangsmåde, fremstillingsform og anvendelse | |
| PL2908835T3 (pl) | Stabilne formulacje | |
| DK2931042T3 (da) | Anthracyclinformuleringer | |
| IL280316B (en) | Bolaamphiphilic compounds, compositions and uses thereof | |
| DE112013002488T8 (de) | Vesikuläre Formulierungen, Kits und Verwendungen | |
| FI20136136A7 (fi) | Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö | |
| EP2945703A4 (en) | ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF | |
| DK2900234T3 (da) | Kræft-kemoterapeutisk middel/formulering, fremstilling og anvendelse deraf | |
| BR112015001169A2 (pt) | polimorfo, uso do polimorfo, composição farmacêutica e uso para preparar o polimorfo |